These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 8176249
1. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. Onodera Y, Shimizu H, Hashimoto T, Ishiko A, Ebihara T, Tanaka M, Nishikawa T. J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249 [Abstract] [Full Text] [Related]
2. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T. J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575 [Abstract] [Full Text] [Related]
5. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain. Egan CA, Taylor TB, Meyer LJ, Petersen MJ, Zone JJ. J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788 [Abstract] [Full Text] [Related]
6. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin. Gao SQ, Bystryn JC. J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753 [Abstract] [Full Text] [Related]
7. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies. Iwasaki T, Olivry T, Lapiere JC, Chan LS, Peavey C, Liu YY, Jones JC, Ihrke PJ, Woodley DT. Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213 [Abstract] [Full Text] [Related]
8. Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid. Sato M, Shimizu H, Ishiko A, Masunaga T, Akiyama M, Hashimoto T, Kitajima Y, Nishikawa T. Br J Dermatol; 1998 Jun; 138(6):965-71. PubMed ID: 9747356 [Abstract] [Full Text] [Related]
16. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies. Xu L, O'Toole EA, Olivry T, Hernandez C, Peng J, Chen M, Chan LS. Biochim Biophys Acta; 2000 Jan 03; 1500(1):97-107. PubMed ID: 10564722 [Abstract] [Full Text] [Related]
17. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Carrozzo M, Cozzani E, Broccoletti R, Carbone M, Pentenero M, Arduino P, Parodi A, Gandolfo S. J Periodontol; 2004 Oct 03; 75(10):1302-8. PubMed ID: 15562906 [Abstract] [Full Text] [Related]
18. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid. Seishima M, Izumi T, Kitajima Y. Eur J Dermatol; 1999 Oct 03; 9(1):39-42. PubMed ID: 9920986 [Abstract] [Full Text] [Related]
19. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens. Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A. J Invest Dermatol; 1997 Jun 03; 108(6):854-8. PubMed ID: 9182810 [Abstract] [Full Text] [Related]